Global Personalized Medicine and Epigenomics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Personalized Medicine and Epigenomics market size was valued at US$ million in 2023. With growing demand in downstream market, the Personalized Medicine and Epigenomics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Personalized Medicine and Epigenomics market. Personalized Medicine and Epigenomics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Personalized Medicine and Epigenomics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Personalized Medicine and Epigenomics market.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Personalized Medicine and Epigenomics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Personalized Medicine and Epigenomics market. It may include historical data, market segmentation by Type (e.g., Reagents, Kits), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Personalized Medicine and Epigenomics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Personalized Medicine and Epigenomics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Personalized Medicine and Epigenomics industry. This include advancements in Personalized Medicine and Epigenomics technology, Personalized Medicine and Epigenomics new entrants, Personalized Medicine and Epigenomics new investment, and other innovations that are shaping the future of Personalized Medicine and Epigenomics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Personalized Medicine and Epigenomics market. It includes factors influencing customer ' purchasing decisions, preferences for Personalized Medicine and Epigenomics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Personalized Medicine and Epigenomics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Personalized Medicine and Epigenomics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Personalized Medicine and Epigenomics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Personalized Medicine and Epigenomics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Personalized Medicine and Epigenomics market.
Market Segmentation:
Personalized Medicine and Epigenomics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Personalized Medicine and Epigenomics market size was valued at US$ million in 2023. With growing demand in downstream market, the Personalized Medicine and Epigenomics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Personalized Medicine and Epigenomics market. Personalized Medicine and Epigenomics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Personalized Medicine and Epigenomics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Personalized Medicine and Epigenomics market.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Personalized Medicine and Epigenomics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Personalized Medicine and Epigenomics market. It may include historical data, market segmentation by Type (e.g., Reagents, Kits), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Personalized Medicine and Epigenomics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Personalized Medicine and Epigenomics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Personalized Medicine and Epigenomics industry. This include advancements in Personalized Medicine and Epigenomics technology, Personalized Medicine and Epigenomics new entrants, Personalized Medicine and Epigenomics new investment, and other innovations that are shaping the future of Personalized Medicine and Epigenomics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Personalized Medicine and Epigenomics market. It includes factors influencing customer ' purchasing decisions, preferences for Personalized Medicine and Epigenomics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Personalized Medicine and Epigenomics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Personalized Medicine and Epigenomics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Personalized Medicine and Epigenomics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Personalized Medicine and Epigenomics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Personalized Medicine and Epigenomics market.
Market Segmentation:
Personalized Medicine and Epigenomics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Reagents
- Kits
- Instruments
- Enzymes
- Services
- Oncology
- Non-Oncology
- Cancer Drug Technology
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott Laboratories
- Affymetrix
- Agilent Technologies
- Astellas Pharmaceuticals
- BAYER AG
- Bio Vision
- Celgene Corp.
- Emd Millipore
- Epigenomics AG
- Epigentex
- Envivo Pharmaceuticals (Forum Pharmaceutricals)
- Gilead Sciences
- Glaxosmithkline
- Illumina Inc.
- Johnson & Johnson
- Karus Therapeutics Limited
- Laboratory Corp. Of America Holdings
- LES Laboratoires Servier
- Merck
- Naturewise Biotech & Medicals Corp.
- Novartis Pharma AG
- Oncolys Biopharma Inc.
- Orchid Chemicals & Pharmaceuticals Limited
- Progen Pharmaceuticals Limited
- Quest Diagnostics
- Roche Holding AG
- Rubicon Genomics
- Takeda Pharmaceutical Company Limited
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Personalized Medicine and Epigenomics Market Size 2019-2030
2.1.2 Personalized Medicine and Epigenomics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Personalized Medicine and Epigenomics Segment by Type
2.2.1 Reagents
2.2.2 Kits
2.2.3 Instruments
2.2.4 Enzymes
2.2.5 Services
2.3 Personalized Medicine and Epigenomics Market Size by Type
2.3.1 Personalized Medicine and Epigenomics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Personalized Medicine and Epigenomics Market Size Market Share by Type (2019-2024)
2.4 Personalized Medicine and Epigenomics Segment by Application
2.4.1 Oncology
2.4.2 Non-Oncology
2.4.3 Cancer Drug Technology
2.5 Personalized Medicine and Epigenomics Market Size by Application
2.5.1 Personalized Medicine and Epigenomics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Personalized Medicine and Epigenomics Market Size Market Share by Application (2019-2024)
3 PERSONALIZED MEDICINE AND EPIGENOMICS MARKET SIZE BY PLAYER
3.1 Personalized Medicine and Epigenomics Market Size Market Share by Players
3.1.1 Global Personalized Medicine and Epigenomics Revenue by Players (2019-2024)
3.1.2 Global Personalized Medicine and Epigenomics Revenue Market Share by Players (2019-2024)
3.2 Global Personalized Medicine and Epigenomics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PERSONALIZED MEDICINE AND EPIGENOMICS BY REGIONS
4.1 Personalized Medicine and Epigenomics Market Size by Regions (2019-2024)
4.2 Americas Personalized Medicine and Epigenomics Market Size Growth (2019-2024)
4.3 APAC Personalized Medicine and Epigenomics Market Size Growth (2019-2024)
4.4 Europe Personalized Medicine and Epigenomics Market Size Growth (2019-2024)
4.5 Middle East & Africa Personalized Medicine and Epigenomics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Personalized Medicine and Epigenomics Market Size by Country (2019-2024)
5.2 Americas Personalized Medicine and Epigenomics Market Size by Type (2019-2024)
5.3 Americas Personalized Medicine and Epigenomics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Personalized Medicine and Epigenomics Market Size by Region (2019-2024)
6.2 APAC Personalized Medicine and Epigenomics Market Size by Type (2019-2024)
6.3 APAC Personalized Medicine and Epigenomics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Personalized Medicine and Epigenomics by Country (2019-2024)
7.2 Europe Personalized Medicine and Epigenomics Market Size by Type (2019-2024)
7.3 Europe Personalized Medicine and Epigenomics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Personalized Medicine and Epigenomics by Region (2019-2024)
8.2 Middle East & Africa Personalized Medicine and Epigenomics Market Size by Type (2019-2024)
8.3 Middle East & Africa Personalized Medicine and Epigenomics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PERSONALIZED MEDICINE AND EPIGENOMICS MARKET FORECAST
10.1 Global Personalized Medicine and Epigenomics Forecast by Regions (2025-2030)
10.1.1 Global Personalized Medicine and Epigenomics Forecast by Regions (2025-2030)
10.1.2 Americas Personalized Medicine and Epigenomics Forecast
10.1.3 APAC Personalized Medicine and Epigenomics Forecast
10.1.4 Europe Personalized Medicine and Epigenomics Forecast
10.1.5 Middle East & Africa Personalized Medicine and Epigenomics Forecast
10.2 Americas Personalized Medicine and Epigenomics Forecast by Country (2025-2030)
10.2.1 United States Personalized Medicine and Epigenomics Market Forecast
10.2.2 Canada Personalized Medicine and Epigenomics Market Forecast
10.2.3 Mexico Personalized Medicine and Epigenomics Market Forecast
10.2.4 Brazil Personalized Medicine and Epigenomics Market Forecast
10.3 APAC Personalized Medicine and Epigenomics Forecast by Region (2025-2030)
10.3.1 China Personalized Medicine and Epigenomics Market Forecast
10.3.2 Japan Personalized Medicine and Epigenomics Market Forecast
10.3.3 Korea Personalized Medicine and Epigenomics Market Forecast
10.3.4 Southeast Asia Personalized Medicine and Epigenomics Market Forecast
10.3.5 India Personalized Medicine and Epigenomics Market Forecast
10.3.6 Australia Personalized Medicine and Epigenomics Market Forecast
10.4 Europe Personalized Medicine and Epigenomics Forecast by Country (2025-2030)
10.4.1 Germany Personalized Medicine and Epigenomics Market Forecast
10.4.2 France Personalized Medicine and Epigenomics Market Forecast
10.4.3 UK Personalized Medicine and Epigenomics Market Forecast
10.4.4 Italy Personalized Medicine and Epigenomics Market Forecast
10.4.5 Russia Personalized Medicine and Epigenomics Market Forecast
10.5 Middle East & Africa Personalized Medicine and Epigenomics Forecast by Region (2025-2030)
10.5.1 Egypt Personalized Medicine and Epigenomics Market Forecast
10.5.2 South Africa Personalized Medicine and Epigenomics Market Forecast
10.5.3 Israel Personalized Medicine and Epigenomics Market Forecast
10.5.4 Turkey Personalized Medicine and Epigenomics Market Forecast
10.5.5 GCC Countries Personalized Medicine and Epigenomics Market Forecast
10.6 Global Personalized Medicine and Epigenomics Forecast by Type (2025-2030)
10.7 Global Personalized Medicine and Epigenomics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Personalized Medicine and Epigenomics Product Offered
11.1.3 Abbott Laboratories Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Affymetrix
11.2.1 Affymetrix Company Information
11.2.2 Affymetrix Personalized Medicine and Epigenomics Product Offered
11.2.3 Affymetrix Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Affymetrix Main Business Overview
11.2.5 Affymetrix Latest Developments
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Information
11.3.2 Agilent Technologies Personalized Medicine and Epigenomics Product Offered
11.3.3 Agilent Technologies Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Agilent Technologies Main Business Overview
11.3.5 Agilent Technologies Latest Developments
11.4 Astellas Pharmaceuticals
11.4.1 Astellas Pharmaceuticals Company Information
11.4.2 Astellas Pharmaceuticals Personalized Medicine and Epigenomics Product Offered
11.4.3 Astellas Pharmaceuticals Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Astellas Pharmaceuticals Main Business Overview
11.4.5 Astellas Pharmaceuticals Latest Developments
11.5 BAYER AG
11.5.1 BAYER AG Company Information
11.5.2 BAYER AG Personalized Medicine and Epigenomics Product Offered
11.5.3 BAYER AG Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 BAYER AG Main Business Overview
11.5.5 BAYER AG Latest Developments
11.6 Bio Vision
11.6.1 Bio Vision Company Information
11.6.2 Bio Vision Personalized Medicine and Epigenomics Product Offered
11.6.3 Bio Vision Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Bio Vision Main Business Overview
11.6.5 Bio Vision Latest Developments
11.7 Celgene Corp.
11.7.1 Celgene Corp. Company Information
11.7.2 Celgene Corp. Personalized Medicine and Epigenomics Product Offered
11.7.3 Celgene Corp. Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Celgene Corp. Main Business Overview
11.7.5 Celgene Corp. Latest Developments
11.8 Emd Millipore
11.8.1 Emd Millipore Company Information
11.8.2 Emd Millipore Personalized Medicine and Epigenomics Product Offered
11.8.3 Emd Millipore Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Emd Millipore Main Business Overview
11.8.5 Emd Millipore Latest Developments
11.9 Epigenomics AG
11.9.1 Epigenomics AG Company Information
11.9.2 Epigenomics AG Personalized Medicine and Epigenomics Product Offered
11.9.3 Epigenomics AG Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Epigenomics AG Main Business Overview
11.9.5 Epigenomics AG Latest Developments
11.10 Epigentex
11.10.1 Epigentex Company Information
11.10.2 Epigentex Personalized Medicine and Epigenomics Product Offered
11.10.3 Epigentex Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Epigentex Main Business Overview
11.10.5 Epigentex Latest Developments
11.11 Envivo Pharmaceuticals (Forum Pharmaceutricals)
11.11.1 Envivo Pharmaceuticals (Forum Pharmaceutricals) Company Information
11.11.2 Envivo Pharmaceuticals (Forum Pharmaceutricals) Personalized Medicine and Epigenomics Product Offered
11.11.3 Envivo Pharmaceuticals (Forum Pharmaceutricals) Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Envivo Pharmaceuticals (Forum Pharmaceutricals) Main Business Overview
11.11.5 Envivo Pharmaceuticals (Forum Pharmaceutricals) Latest Developments
11.12 Gilead Sciences
11.12.1 Gilead Sciences Company Information
11.12.2 Gilead Sciences Personalized Medicine and Epigenomics Product Offered
11.12.3 Gilead Sciences Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Gilead Sciences Main Business Overview
11.12.5 Gilead Sciences Latest Developments
11.13 Glaxosmithkline
11.13.1 Glaxosmithkline Company Information
11.13.2 Glaxosmithkline Personalized Medicine and Epigenomics Product Offered
11.13.3 Glaxosmithkline Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Glaxosmithkline Main Business Overview
11.13.5 Glaxosmithkline Latest Developments
11.14 Illumina Inc.
11.14.1 Illumina Inc. Company Information
11.14.2 Illumina Inc. Personalized Medicine and Epigenomics Product Offered
11.14.3 Illumina Inc. Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Illumina Inc. Main Business Overview
11.14.5 Illumina Inc. Latest Developments
11.15 Johnson & Johnson
11.15.1 Johnson & Johnson Company Information
11.15.2 Johnson & Johnson Personalized Medicine and Epigenomics Product Offered
11.15.3 Johnson & Johnson Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Johnson & Johnson Main Business Overview
11.15.5 Johnson & Johnson Latest Developments
11.16 Karus Therapeutics Limited
11.16.1 Karus Therapeutics Limited Company Information
11.16.2 Karus Therapeutics Limited Personalized Medicine and Epigenomics Product Offered
11.16.3 Karus Therapeutics Limited Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Karus Therapeutics Limited Main Business Overview
11.16.5 Karus Therapeutics Limited Latest Developments
11.17 Laboratory Corp. Of America Holdings
11.17.1 Laboratory Corp. Of America Holdings Company Information
11.17.2 Laboratory Corp. Of America Holdings Personalized Medicine and Epigenomics Product Offered
11.17.3 Laboratory Corp. Of America Holdings Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Laboratory Corp. Of America Holdings Main Business Overview
11.17.5 Laboratory Corp. Of America Holdings Latest Developments
11.18 LES Laboratoires Servier
11.18.1 LES Laboratoires Servier Company Information
11.18.2 LES Laboratoires Servier Personalized Medicine and Epigenomics Product Offered
11.18.3 LES Laboratoires Servier Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 LES Laboratoires Servier Main Business Overview
11.18.5 LES Laboratoires Servier Latest Developments
11.19 Merck
11.19.1 Merck Company Information
11.19.2 Merck Personalized Medicine and Epigenomics Product Offered
11.19.3 Merck Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Merck Main Business Overview
11.19.5 Merck Latest Developments
11.20 Naturewise Biotech & Medicals Corp.
11.20.1 Naturewise Biotech & Medicals Corp. Company Information
11.20.2 Naturewise Biotech & Medicals Corp. Personalized Medicine and Epigenomics Product Offered
11.20.3 Naturewise Biotech & Medicals Corp. Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Naturewise Biotech & Medicals Corp. Main Business Overview
11.20.5 Naturewise Biotech & Medicals Corp. Latest Developments
11.21 Novartis Pharma AG
11.21.1 Novartis Pharma AG Company Information
11.21.2 Novartis Pharma AG Personalized Medicine and Epigenomics Product Offered
11.21.3 Novartis Pharma AG Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Novartis Pharma AG Main Business Overview
11.21.5 Novartis Pharma AG Latest Developments
11.22 Oncolys Biopharma Inc.
11.22.1 Oncolys Biopharma Inc. Company Information
11.22.2 Oncolys Biopharma Inc. Personalized Medicine and Epigenomics Product Offered
11.22.3 Oncolys Biopharma Inc. Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 Oncolys Biopharma Inc. Main Business Overview
11.22.5 Oncolys Biopharma Inc. Latest Developments
11.23 Orchid Chemicals & Pharmaceuticals Limited
11.23.1 Orchid Chemicals & Pharmaceuticals Limited Company Information
11.23.2 Orchid Chemicals & Pharmaceuticals Limited Personalized Medicine and Epigenomics Product Offered
11.23.3 Orchid Chemicals & Pharmaceuticals Limited Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.23.4 Orchid Chemicals & Pharmaceuticals Limited Main Business Overview
11.23.5 Orchid Chemicals & Pharmaceuticals Limited Latest Developments
11.24 Progen Pharmaceuticals Limited
11.24.1 Progen Pharmaceuticals Limited Company Information
11.24.2 Progen Pharmaceuticals Limited Personalized Medicine and Epigenomics Product Offered
11.24.3 Progen Pharmaceuticals Limited Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.24.4 Progen Pharmaceuticals Limited Main Business Overview
11.24.5 Progen Pharmaceuticals Limited Latest Developments
11.25 Quest Diagnostics
11.25.1 Quest Diagnostics Company Information
11.25.2 Quest Diagnostics Personalized Medicine and Epigenomics Product Offered
11.25.3 Quest Diagnostics Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.25.4 Quest Diagnostics Main Business Overview
11.25.5 Quest Diagnostics Latest Developments
11.26 Roche Holding AG
11.26.1 Roche Holding AG Company Information
11.26.2 Roche Holding AG Personalized Medicine and Epigenomics Product Offered
11.26.3 Roche Holding AG Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.26.4 Roche Holding AG Main Business Overview
11.26.5 Roche Holding AG Latest Developments
11.27 Rubicon Genomics
11.27.1 Rubicon Genomics Company Information
11.27.2 Rubicon Genomics Personalized Medicine and Epigenomics Product Offered
11.27.3 Rubicon Genomics Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.27.4 Rubicon Genomics Main Business Overview
11.27.5 Rubicon Genomics Latest Developments
11.28 Takeda Pharmaceutical Company Limited
11.28.1 Takeda Pharmaceutical Company Limited Company Information
11.28.2 Takeda Pharmaceutical Company Limited Personalized Medicine and Epigenomics Product Offered
11.28.3 Takeda Pharmaceutical Company Limited Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.28.4 Takeda Pharmaceutical Company Limited Main Business Overview
11.28.5 Takeda Pharmaceutical Company Limited Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Personalized Medicine and Epigenomics Market Size 2019-2030
2.1.2 Personalized Medicine and Epigenomics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Personalized Medicine and Epigenomics Segment by Type
2.2.1 Reagents
2.2.2 Kits
2.2.3 Instruments
2.2.4 Enzymes
2.2.5 Services
2.3 Personalized Medicine and Epigenomics Market Size by Type
2.3.1 Personalized Medicine and Epigenomics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Personalized Medicine and Epigenomics Market Size Market Share by Type (2019-2024)
2.4 Personalized Medicine and Epigenomics Segment by Application
2.4.1 Oncology
2.4.2 Non-Oncology
2.4.3 Cancer Drug Technology
2.5 Personalized Medicine and Epigenomics Market Size by Application
2.5.1 Personalized Medicine and Epigenomics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Personalized Medicine and Epigenomics Market Size Market Share by Application (2019-2024)
3 PERSONALIZED MEDICINE AND EPIGENOMICS MARKET SIZE BY PLAYER
3.1 Personalized Medicine and Epigenomics Market Size Market Share by Players
3.1.1 Global Personalized Medicine and Epigenomics Revenue by Players (2019-2024)
3.1.2 Global Personalized Medicine and Epigenomics Revenue Market Share by Players (2019-2024)
3.2 Global Personalized Medicine and Epigenomics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PERSONALIZED MEDICINE AND EPIGENOMICS BY REGIONS
4.1 Personalized Medicine and Epigenomics Market Size by Regions (2019-2024)
4.2 Americas Personalized Medicine and Epigenomics Market Size Growth (2019-2024)
4.3 APAC Personalized Medicine and Epigenomics Market Size Growth (2019-2024)
4.4 Europe Personalized Medicine and Epigenomics Market Size Growth (2019-2024)
4.5 Middle East & Africa Personalized Medicine and Epigenomics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Personalized Medicine and Epigenomics Market Size by Country (2019-2024)
5.2 Americas Personalized Medicine and Epigenomics Market Size by Type (2019-2024)
5.3 Americas Personalized Medicine and Epigenomics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Personalized Medicine and Epigenomics Market Size by Region (2019-2024)
6.2 APAC Personalized Medicine and Epigenomics Market Size by Type (2019-2024)
6.3 APAC Personalized Medicine and Epigenomics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Personalized Medicine and Epigenomics by Country (2019-2024)
7.2 Europe Personalized Medicine and Epigenomics Market Size by Type (2019-2024)
7.3 Europe Personalized Medicine and Epigenomics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Personalized Medicine and Epigenomics by Region (2019-2024)
8.2 Middle East & Africa Personalized Medicine and Epigenomics Market Size by Type (2019-2024)
8.3 Middle East & Africa Personalized Medicine and Epigenomics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PERSONALIZED MEDICINE AND EPIGENOMICS MARKET FORECAST
10.1 Global Personalized Medicine and Epigenomics Forecast by Regions (2025-2030)
10.1.1 Global Personalized Medicine and Epigenomics Forecast by Regions (2025-2030)
10.1.2 Americas Personalized Medicine and Epigenomics Forecast
10.1.3 APAC Personalized Medicine and Epigenomics Forecast
10.1.4 Europe Personalized Medicine and Epigenomics Forecast
10.1.5 Middle East & Africa Personalized Medicine and Epigenomics Forecast
10.2 Americas Personalized Medicine and Epigenomics Forecast by Country (2025-2030)
10.2.1 United States Personalized Medicine and Epigenomics Market Forecast
10.2.2 Canada Personalized Medicine and Epigenomics Market Forecast
10.2.3 Mexico Personalized Medicine and Epigenomics Market Forecast
10.2.4 Brazil Personalized Medicine and Epigenomics Market Forecast
10.3 APAC Personalized Medicine and Epigenomics Forecast by Region (2025-2030)
10.3.1 China Personalized Medicine and Epigenomics Market Forecast
10.3.2 Japan Personalized Medicine and Epigenomics Market Forecast
10.3.3 Korea Personalized Medicine and Epigenomics Market Forecast
10.3.4 Southeast Asia Personalized Medicine and Epigenomics Market Forecast
10.3.5 India Personalized Medicine and Epigenomics Market Forecast
10.3.6 Australia Personalized Medicine and Epigenomics Market Forecast
10.4 Europe Personalized Medicine and Epigenomics Forecast by Country (2025-2030)
10.4.1 Germany Personalized Medicine and Epigenomics Market Forecast
10.4.2 France Personalized Medicine and Epigenomics Market Forecast
10.4.3 UK Personalized Medicine and Epigenomics Market Forecast
10.4.4 Italy Personalized Medicine and Epigenomics Market Forecast
10.4.5 Russia Personalized Medicine and Epigenomics Market Forecast
10.5 Middle East & Africa Personalized Medicine and Epigenomics Forecast by Region (2025-2030)
10.5.1 Egypt Personalized Medicine and Epigenomics Market Forecast
10.5.2 South Africa Personalized Medicine and Epigenomics Market Forecast
10.5.3 Israel Personalized Medicine and Epigenomics Market Forecast
10.5.4 Turkey Personalized Medicine and Epigenomics Market Forecast
10.5.5 GCC Countries Personalized Medicine and Epigenomics Market Forecast
10.6 Global Personalized Medicine and Epigenomics Forecast by Type (2025-2030)
10.7 Global Personalized Medicine and Epigenomics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Personalized Medicine and Epigenomics Product Offered
11.1.3 Abbott Laboratories Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Affymetrix
11.2.1 Affymetrix Company Information
11.2.2 Affymetrix Personalized Medicine and Epigenomics Product Offered
11.2.3 Affymetrix Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Affymetrix Main Business Overview
11.2.5 Affymetrix Latest Developments
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Information
11.3.2 Agilent Technologies Personalized Medicine and Epigenomics Product Offered
11.3.3 Agilent Technologies Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Agilent Technologies Main Business Overview
11.3.5 Agilent Technologies Latest Developments
11.4 Astellas Pharmaceuticals
11.4.1 Astellas Pharmaceuticals Company Information
11.4.2 Astellas Pharmaceuticals Personalized Medicine and Epigenomics Product Offered
11.4.3 Astellas Pharmaceuticals Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Astellas Pharmaceuticals Main Business Overview
11.4.5 Astellas Pharmaceuticals Latest Developments
11.5 BAYER AG
11.5.1 BAYER AG Company Information
11.5.2 BAYER AG Personalized Medicine and Epigenomics Product Offered
11.5.3 BAYER AG Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 BAYER AG Main Business Overview
11.5.5 BAYER AG Latest Developments
11.6 Bio Vision
11.6.1 Bio Vision Company Information
11.6.2 Bio Vision Personalized Medicine and Epigenomics Product Offered
11.6.3 Bio Vision Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Bio Vision Main Business Overview
11.6.5 Bio Vision Latest Developments
11.7 Celgene Corp.
11.7.1 Celgene Corp. Company Information
11.7.2 Celgene Corp. Personalized Medicine and Epigenomics Product Offered
11.7.3 Celgene Corp. Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Celgene Corp. Main Business Overview
11.7.5 Celgene Corp. Latest Developments
11.8 Emd Millipore
11.8.1 Emd Millipore Company Information
11.8.2 Emd Millipore Personalized Medicine and Epigenomics Product Offered
11.8.3 Emd Millipore Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Emd Millipore Main Business Overview
11.8.5 Emd Millipore Latest Developments
11.9 Epigenomics AG
11.9.1 Epigenomics AG Company Information
11.9.2 Epigenomics AG Personalized Medicine and Epigenomics Product Offered
11.9.3 Epigenomics AG Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Epigenomics AG Main Business Overview
11.9.5 Epigenomics AG Latest Developments
11.10 Epigentex
11.10.1 Epigentex Company Information
11.10.2 Epigentex Personalized Medicine and Epigenomics Product Offered
11.10.3 Epigentex Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Epigentex Main Business Overview
11.10.5 Epigentex Latest Developments
11.11 Envivo Pharmaceuticals (Forum Pharmaceutricals)
11.11.1 Envivo Pharmaceuticals (Forum Pharmaceutricals) Company Information
11.11.2 Envivo Pharmaceuticals (Forum Pharmaceutricals) Personalized Medicine and Epigenomics Product Offered
11.11.3 Envivo Pharmaceuticals (Forum Pharmaceutricals) Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Envivo Pharmaceuticals (Forum Pharmaceutricals) Main Business Overview
11.11.5 Envivo Pharmaceuticals (Forum Pharmaceutricals) Latest Developments
11.12 Gilead Sciences
11.12.1 Gilead Sciences Company Information
11.12.2 Gilead Sciences Personalized Medicine and Epigenomics Product Offered
11.12.3 Gilead Sciences Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Gilead Sciences Main Business Overview
11.12.5 Gilead Sciences Latest Developments
11.13 Glaxosmithkline
11.13.1 Glaxosmithkline Company Information
11.13.2 Glaxosmithkline Personalized Medicine and Epigenomics Product Offered
11.13.3 Glaxosmithkline Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Glaxosmithkline Main Business Overview
11.13.5 Glaxosmithkline Latest Developments
11.14 Illumina Inc.
11.14.1 Illumina Inc. Company Information
11.14.2 Illumina Inc. Personalized Medicine and Epigenomics Product Offered
11.14.3 Illumina Inc. Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Illumina Inc. Main Business Overview
11.14.5 Illumina Inc. Latest Developments
11.15 Johnson & Johnson
11.15.1 Johnson & Johnson Company Information
11.15.2 Johnson & Johnson Personalized Medicine and Epigenomics Product Offered
11.15.3 Johnson & Johnson Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Johnson & Johnson Main Business Overview
11.15.5 Johnson & Johnson Latest Developments
11.16 Karus Therapeutics Limited
11.16.1 Karus Therapeutics Limited Company Information
11.16.2 Karus Therapeutics Limited Personalized Medicine and Epigenomics Product Offered
11.16.3 Karus Therapeutics Limited Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Karus Therapeutics Limited Main Business Overview
11.16.5 Karus Therapeutics Limited Latest Developments
11.17 Laboratory Corp. Of America Holdings
11.17.1 Laboratory Corp. Of America Holdings Company Information
11.17.2 Laboratory Corp. Of America Holdings Personalized Medicine and Epigenomics Product Offered
11.17.3 Laboratory Corp. Of America Holdings Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Laboratory Corp. Of America Holdings Main Business Overview
11.17.5 Laboratory Corp. Of America Holdings Latest Developments
11.18 LES Laboratoires Servier
11.18.1 LES Laboratoires Servier Company Information
11.18.2 LES Laboratoires Servier Personalized Medicine and Epigenomics Product Offered
11.18.3 LES Laboratoires Servier Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 LES Laboratoires Servier Main Business Overview
11.18.5 LES Laboratoires Servier Latest Developments
11.19 Merck
11.19.1 Merck Company Information
11.19.2 Merck Personalized Medicine and Epigenomics Product Offered
11.19.3 Merck Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Merck Main Business Overview
11.19.5 Merck Latest Developments
11.20 Naturewise Biotech & Medicals Corp.
11.20.1 Naturewise Biotech & Medicals Corp. Company Information
11.20.2 Naturewise Biotech & Medicals Corp. Personalized Medicine and Epigenomics Product Offered
11.20.3 Naturewise Biotech & Medicals Corp. Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Naturewise Biotech & Medicals Corp. Main Business Overview
11.20.5 Naturewise Biotech & Medicals Corp. Latest Developments
11.21 Novartis Pharma AG
11.21.1 Novartis Pharma AG Company Information
11.21.2 Novartis Pharma AG Personalized Medicine and Epigenomics Product Offered
11.21.3 Novartis Pharma AG Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Novartis Pharma AG Main Business Overview
11.21.5 Novartis Pharma AG Latest Developments
11.22 Oncolys Biopharma Inc.
11.22.1 Oncolys Biopharma Inc. Company Information
11.22.2 Oncolys Biopharma Inc. Personalized Medicine and Epigenomics Product Offered
11.22.3 Oncolys Biopharma Inc. Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 Oncolys Biopharma Inc. Main Business Overview
11.22.5 Oncolys Biopharma Inc. Latest Developments
11.23 Orchid Chemicals & Pharmaceuticals Limited
11.23.1 Orchid Chemicals & Pharmaceuticals Limited Company Information
11.23.2 Orchid Chemicals & Pharmaceuticals Limited Personalized Medicine and Epigenomics Product Offered
11.23.3 Orchid Chemicals & Pharmaceuticals Limited Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.23.4 Orchid Chemicals & Pharmaceuticals Limited Main Business Overview
11.23.5 Orchid Chemicals & Pharmaceuticals Limited Latest Developments
11.24 Progen Pharmaceuticals Limited
11.24.1 Progen Pharmaceuticals Limited Company Information
11.24.2 Progen Pharmaceuticals Limited Personalized Medicine and Epigenomics Product Offered
11.24.3 Progen Pharmaceuticals Limited Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.24.4 Progen Pharmaceuticals Limited Main Business Overview
11.24.5 Progen Pharmaceuticals Limited Latest Developments
11.25 Quest Diagnostics
11.25.1 Quest Diagnostics Company Information
11.25.2 Quest Diagnostics Personalized Medicine and Epigenomics Product Offered
11.25.3 Quest Diagnostics Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.25.4 Quest Diagnostics Main Business Overview
11.25.5 Quest Diagnostics Latest Developments
11.26 Roche Holding AG
11.26.1 Roche Holding AG Company Information
11.26.2 Roche Holding AG Personalized Medicine and Epigenomics Product Offered
11.26.3 Roche Holding AG Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.26.4 Roche Holding AG Main Business Overview
11.26.5 Roche Holding AG Latest Developments
11.27 Rubicon Genomics
11.27.1 Rubicon Genomics Company Information
11.27.2 Rubicon Genomics Personalized Medicine and Epigenomics Product Offered
11.27.3 Rubicon Genomics Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.27.4 Rubicon Genomics Main Business Overview
11.27.5 Rubicon Genomics Latest Developments
11.28 Takeda Pharmaceutical Company Limited
11.28.1 Takeda Pharmaceutical Company Limited Company Information
11.28.2 Takeda Pharmaceutical Company Limited Personalized Medicine and Epigenomics Product Offered
11.28.3 Takeda Pharmaceutical Company Limited Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2024)
11.28.4 Takeda Pharmaceutical Company Limited Main Business Overview
11.28.5 Takeda Pharmaceutical Company Limited Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Personalized Medicine and Epigenomics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Reagents
Table 3. Major Players of Kits
Table 4. Major Players of Instruments
Table 5. Major Players of Enzymes
Table 6. Major Players of Services
Table 7. Personalized Medicine and Epigenomics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Personalized Medicine and Epigenomics Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Personalized Medicine and Epigenomics Market Size Market Share by Type (2019-2024)
Table 10. Personalized Medicine and Epigenomics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Personalized Medicine and Epigenomics Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Personalized Medicine and Epigenomics Market Size Market Share by Application (2019-2024)
Table 13. Global Personalized Medicine and Epigenomics Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Personalized Medicine and Epigenomics Revenue Market Share by Player (2019-2024)
Table 15. Personalized Medicine and Epigenomics Key Players Head office and Products Offered
Table 16. Personalized Medicine and Epigenomics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Personalized Medicine and Epigenomics Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Personalized Medicine and Epigenomics Market Size Market Share by Regions (2019-2024)
Table 21. Global Personalized Medicine and Epigenomics Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Personalized Medicine and Epigenomics Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Personalized Medicine and Epigenomics Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Personalized Medicine and Epigenomics Market Size Market Share by Country (2019-2024)
Table 25. Americas Personalized Medicine and Epigenomics Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Personalized Medicine and Epigenomics Market Size Market Share by Type (2019-2024)
Table 27. Americas Personalized Medicine and Epigenomics Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Personalized Medicine and Epigenomics Market Size Market Share by Application (2019-2024)
Table 29. APAC Personalized Medicine and Epigenomics Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Personalized Medicine and Epigenomics Market Size Market Share by Region (2019-2024)
Table 31. APAC Personalized Medicine and Epigenomics Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Personalized Medicine and Epigenomics Market Size Market Share by Type (2019-2024)
Table 33. APAC Personalized Medicine and Epigenomics Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Personalized Medicine and Epigenomics Market Size Market Share by Application (2019-2024)
Table 35. Europe Personalized Medicine and Epigenomics Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Personalized Medicine and Epigenomics Market Size Market Share by Country (2019-2024)
Table 37. Europe Personalized Medicine and Epigenomics Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Personalized Medicine and Epigenomics Market Size Market Share by Type (2019-2024)
Table 39. Europe Personalized Medicine and Epigenomics Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Personalized Medicine and Epigenomics Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Personalized Medicine and Epigenomics Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Personalized Medicine and Epigenomics Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Personalized Medicine and Epigenomics Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Personalized Medicine and Epigenomics Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Personalized Medicine and Epigenomics Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Personalized Medicine and Epigenomics Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Personalized Medicine and Epigenomics
Table 48. Key Market Challenges & Risks of Personalized Medicine and Epigenomics
Table 49. Key Industry Trends of Personalized Medicine and Epigenomics
Table 50. Global Personalized Medicine and Epigenomics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Personalized Medicine and Epigenomics Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Personalized Medicine and Epigenomics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Personalized Medicine and Epigenomics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Abbott Laboratories Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 55. Abbott Laboratories Personalized Medicine and Epigenomics Product Offered
Table 56. Abbott Laboratories Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Abbott Laboratories Main Business
Table 58. Abbott Laboratories Latest Developments
Table 59. Affymetrix Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 60. Affymetrix Personalized Medicine and Epigenomics Product Offered
Table 61. Affymetrix Main Business
Table 62. Affymetrix Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Affymetrix Latest Developments
Table 64. Agilent Technologies Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 65. Agilent Technologies Personalized Medicine and Epigenomics Product Offered
Table 66. Agilent Technologies Main Business
Table 67. Agilent Technologies Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Agilent Technologies Latest Developments
Table 69. Astellas Pharmaceuticals Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 70. Astellas Pharmaceuticals Personalized Medicine and Epigenomics Product Offered
Table 71. Astellas Pharmaceuticals Main Business
Table 72. Astellas Pharmaceuticals Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Astellas Pharmaceuticals Latest Developments
Table 74. BAYER AG Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 75. BAYER AG Personalized Medicine and Epigenomics Product Offered
Table 76. BAYER AG Main Business
Table 77. BAYER AG Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. BAYER AG Latest Developments
Table 79. Bio Vision Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 80. Bio Vision Personalized Medicine and Epigenomics Product Offered
Table 81. Bio Vision Main Business
Table 82. Bio Vision Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Bio Vision Latest Developments
Table 84. Celgene Corp. Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 85. Celgene Corp. Personalized Medicine and Epigenomics Product Offered
Table 86. Celgene Corp. Main Business
Table 87. Celgene Corp. Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Celgene Corp. Latest Developments
Table 89. Emd Millipore Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 90. Emd Millipore Personalized Medicine and Epigenomics Product Offered
Table 91. Emd Millipore Main Business
Table 92. Emd Millipore Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Emd Millipore Latest Developments
Table 94. Epigenomics AG Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 95. Epigenomics AG Personalized Medicine and Epigenomics Product Offered
Table 96. Epigenomics AG Main Business
Table 97. Epigenomics AG Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Epigenomics AG Latest Developments
Table 99. Epigentex Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 100. Epigentex Personalized Medicine and Epigenomics Product Offered
Table 101. Epigentex Main Business
Table 102. Epigentex Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Epigentex Latest Developments
Table 104. Envivo Pharmaceuticals (Forum Pharmaceutricals) Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 105. Envivo Pharmaceuticals (Forum Pharmaceutricals) Personalized Medicine and Epigenomics Product Offered
Table 106. Envivo Pharmaceuticals (Forum Pharmaceutricals) Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. Envivo Pharmaceuticals (Forum Pharmaceutricals) Main Business
Table 108. Envivo Pharmaceuticals (Forum Pharmaceutricals) Latest Developments
Table 109. Gilead Sciences Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 110. Gilead Sciences Personalized Medicine and Epigenomics Product Offered
Table 111. Gilead Sciences Main Business
Table 112. Gilead Sciences Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 113. Gilead Sciences Latest Developments
Table 114. Glaxosmithkline Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 115. Glaxosmithkline Personalized Medicine and Epigenomics Product Offered
Table 116. Glaxosmithkline Main Business
Table 117. Glaxosmithkline Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. Glaxosmithkline Latest Developments
Table 119. Illumina Inc. Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 120. Illumina Inc. Personalized Medicine and Epigenomics Product Offered
Table 121. Illumina Inc. Main Business
Table 122. Illumina Inc. Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 123. Illumina Inc. Latest Developments
Table 124. Johnson & Johnson Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 125. Johnson & Johnson Personalized Medicine and Epigenomics Product Offered
Table 126. Johnson & Johnson Main Business
Table 127. Johnson & Johnson Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 128. Johnson & Johnson Latest Developments
Table 129. Karus Therapeutics Limited Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 130. Karus Therapeutics Limited Personalized Medicine and Epigenomics Product Offered
Table 131. Karus Therapeutics Limited Main Business
Table 132. Karus Therapeutics Limited Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 133. Karus Therapeutics Limited Latest Developments
Table 134. Laboratory Corp. Of America Holdings Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 135. Laboratory Corp. Of America Holdings Personalized Medicine and Epigenomics Product Offered
Table 136. Laboratory Corp. Of America Holdings Main Business
Table 137. Laboratory Corp. Of America Holdings Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 138. Laboratory Corp. Of America Holdings Latest Developments
Table 139. LES Laboratoires Servier Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 140. LES Laboratoires Servier Personalized Medicine and Epigenomics Product Offered
Table 141. LES Laboratoires Servier Main Business
Table 142. LES Laboratoires Servier Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 143. LES Laboratoires Servier Latest Developments
Table 144. Merck Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 145. Merck Personalized Medicine and Epigenomics Product Offered
Table 146. Merck Main Business
Table 147. Merck Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 148. Merck Latest Developments
Table 149. Naturewise Biotech & Medicals Corp. Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 150. Naturewise Biotech & Medicals Corp. Personalized Medicine and Epigenomics Product Offered
Table 151. Naturewise Biotech & Medicals Corp. Main Business
Table 152. Naturewise Biotech & Medicals Corp. Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 153. Naturewise Biotech & Medicals Corp. Latest Developments
Table 154. Novartis Pharma AG Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 155. Novartis Pharma AG Personalized Medicine and Epigenomics Product Offered
Table 156. Novartis Pharma AG Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 157. Novartis Pharma AG Main Business
Table 158. Novartis Pharma AG Latest Developments
Table 159. Oncolys Biopharma Inc. Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 160. Oncolys Biopharma Inc. Personalized Medicine and Epigenomics Product Offered
Table 161. Oncolys Biopharma Inc. Main Business
Table 162. Oncolys Biopharma Inc. Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 163. Oncolys Biopharma Inc. Latest Developments
Table 164. Orchid Chemicals & Pharmaceuticals Limited Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 165. Orchid Chemicals & Pharmaceuticals Limited Personalized Medicine and Epigenomics Product Offered
Table 166. Orchid Chemicals & Pharmaceuticals Limited Main Business
Table 167. Orchid Chemicals & Pharmaceuticals Limited Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 168. Orchid Chemicals & Pharmaceuticals Limited Latest Developments
Table 169. Progen Pharmaceuticals Limited Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 170. Progen Pharmaceuticals Limited Personalized Medicine and Epigenomics Product Offered
Table 171. Progen Pharmaceuticals Limited Main Business
Table 172. Progen Pharmaceuticals Limited Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 173. Progen Pharmaceuticals Limited Latest Developments
Table 174. Quest Diagnostics Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 175. Quest Diagnostics Personalized Medicine and Epigenomics Product Offered
Table 176. Quest Diagnostics Main Business
Table 177. Quest Diagnostics Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 178. Quest Diagnostics Latest Developments
Table 179. Roche Holding AG Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 180. Roche Holding AG Personalized Medicine and Epigenomics Product Offered
Table 181. Roche Holding AG Main Business
Table 182. Roche Holding AG Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 183. Roche Holding AG Latest Developments
Table 184. Rubicon Genomics Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 185. Rubicon Genomics Personalized Medicine and Epigenomics Product Offered
Table 186. Rubicon Genomics Main Business
Table 187. Rubicon Genomics Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 188. Rubicon Genomics Latest Developments
Table 189. Takeda Pharmaceutical Company Limited Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 190. Takeda Pharmaceutical Company Limited Personalized Medicine and Epigenomics Product Offered
Table 191. Takeda Pharmaceutical Company Limited Main Business
Table 192. Takeda Pharmaceutical Company Limited Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 193. Takeda Pharmaceutical Company Limited Latest Developments
Table 1. Personalized Medicine and Epigenomics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Reagents
Table 3. Major Players of Kits
Table 4. Major Players of Instruments
Table 5. Major Players of Enzymes
Table 6. Major Players of Services
Table 7. Personalized Medicine and Epigenomics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Personalized Medicine and Epigenomics Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Personalized Medicine and Epigenomics Market Size Market Share by Type (2019-2024)
Table 10. Personalized Medicine and Epigenomics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Personalized Medicine and Epigenomics Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Personalized Medicine and Epigenomics Market Size Market Share by Application (2019-2024)
Table 13. Global Personalized Medicine and Epigenomics Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Personalized Medicine and Epigenomics Revenue Market Share by Player (2019-2024)
Table 15. Personalized Medicine and Epigenomics Key Players Head office and Products Offered
Table 16. Personalized Medicine and Epigenomics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Personalized Medicine and Epigenomics Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Personalized Medicine and Epigenomics Market Size Market Share by Regions (2019-2024)
Table 21. Global Personalized Medicine and Epigenomics Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Personalized Medicine and Epigenomics Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Personalized Medicine and Epigenomics Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Personalized Medicine and Epigenomics Market Size Market Share by Country (2019-2024)
Table 25. Americas Personalized Medicine and Epigenomics Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Personalized Medicine and Epigenomics Market Size Market Share by Type (2019-2024)
Table 27. Americas Personalized Medicine and Epigenomics Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Personalized Medicine and Epigenomics Market Size Market Share by Application (2019-2024)
Table 29. APAC Personalized Medicine and Epigenomics Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Personalized Medicine and Epigenomics Market Size Market Share by Region (2019-2024)
Table 31. APAC Personalized Medicine and Epigenomics Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Personalized Medicine and Epigenomics Market Size Market Share by Type (2019-2024)
Table 33. APAC Personalized Medicine and Epigenomics Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Personalized Medicine and Epigenomics Market Size Market Share by Application (2019-2024)
Table 35. Europe Personalized Medicine and Epigenomics Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Personalized Medicine and Epigenomics Market Size Market Share by Country (2019-2024)
Table 37. Europe Personalized Medicine and Epigenomics Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Personalized Medicine and Epigenomics Market Size Market Share by Type (2019-2024)
Table 39. Europe Personalized Medicine and Epigenomics Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Personalized Medicine and Epigenomics Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Personalized Medicine and Epigenomics Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Personalized Medicine and Epigenomics Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Personalized Medicine and Epigenomics Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Personalized Medicine and Epigenomics Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Personalized Medicine and Epigenomics Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Personalized Medicine and Epigenomics Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Personalized Medicine and Epigenomics
Table 48. Key Market Challenges & Risks of Personalized Medicine and Epigenomics
Table 49. Key Industry Trends of Personalized Medicine and Epigenomics
Table 50. Global Personalized Medicine and Epigenomics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Personalized Medicine and Epigenomics Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Personalized Medicine and Epigenomics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Personalized Medicine and Epigenomics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Abbott Laboratories Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 55. Abbott Laboratories Personalized Medicine and Epigenomics Product Offered
Table 56. Abbott Laboratories Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Abbott Laboratories Main Business
Table 58. Abbott Laboratories Latest Developments
Table 59. Affymetrix Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 60. Affymetrix Personalized Medicine and Epigenomics Product Offered
Table 61. Affymetrix Main Business
Table 62. Affymetrix Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Affymetrix Latest Developments
Table 64. Agilent Technologies Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 65. Agilent Technologies Personalized Medicine and Epigenomics Product Offered
Table 66. Agilent Technologies Main Business
Table 67. Agilent Technologies Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Agilent Technologies Latest Developments
Table 69. Astellas Pharmaceuticals Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 70. Astellas Pharmaceuticals Personalized Medicine and Epigenomics Product Offered
Table 71. Astellas Pharmaceuticals Main Business
Table 72. Astellas Pharmaceuticals Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Astellas Pharmaceuticals Latest Developments
Table 74. BAYER AG Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 75. BAYER AG Personalized Medicine and Epigenomics Product Offered
Table 76. BAYER AG Main Business
Table 77. BAYER AG Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. BAYER AG Latest Developments
Table 79. Bio Vision Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 80. Bio Vision Personalized Medicine and Epigenomics Product Offered
Table 81. Bio Vision Main Business
Table 82. Bio Vision Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Bio Vision Latest Developments
Table 84. Celgene Corp. Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 85. Celgene Corp. Personalized Medicine and Epigenomics Product Offered
Table 86. Celgene Corp. Main Business
Table 87. Celgene Corp. Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Celgene Corp. Latest Developments
Table 89. Emd Millipore Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 90. Emd Millipore Personalized Medicine and Epigenomics Product Offered
Table 91. Emd Millipore Main Business
Table 92. Emd Millipore Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Emd Millipore Latest Developments
Table 94. Epigenomics AG Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 95. Epigenomics AG Personalized Medicine and Epigenomics Product Offered
Table 96. Epigenomics AG Main Business
Table 97. Epigenomics AG Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Epigenomics AG Latest Developments
Table 99. Epigentex Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 100. Epigentex Personalized Medicine and Epigenomics Product Offered
Table 101. Epigentex Main Business
Table 102. Epigentex Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Epigentex Latest Developments
Table 104. Envivo Pharmaceuticals (Forum Pharmaceutricals) Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 105. Envivo Pharmaceuticals (Forum Pharmaceutricals) Personalized Medicine and Epigenomics Product Offered
Table 106. Envivo Pharmaceuticals (Forum Pharmaceutricals) Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. Envivo Pharmaceuticals (Forum Pharmaceutricals) Main Business
Table 108. Envivo Pharmaceuticals (Forum Pharmaceutricals) Latest Developments
Table 109. Gilead Sciences Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 110. Gilead Sciences Personalized Medicine and Epigenomics Product Offered
Table 111. Gilead Sciences Main Business
Table 112. Gilead Sciences Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 113. Gilead Sciences Latest Developments
Table 114. Glaxosmithkline Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 115. Glaxosmithkline Personalized Medicine and Epigenomics Product Offered
Table 116. Glaxosmithkline Main Business
Table 117. Glaxosmithkline Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. Glaxosmithkline Latest Developments
Table 119. Illumina Inc. Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 120. Illumina Inc. Personalized Medicine and Epigenomics Product Offered
Table 121. Illumina Inc. Main Business
Table 122. Illumina Inc. Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 123. Illumina Inc. Latest Developments
Table 124. Johnson & Johnson Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 125. Johnson & Johnson Personalized Medicine and Epigenomics Product Offered
Table 126. Johnson & Johnson Main Business
Table 127. Johnson & Johnson Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 128. Johnson & Johnson Latest Developments
Table 129. Karus Therapeutics Limited Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 130. Karus Therapeutics Limited Personalized Medicine and Epigenomics Product Offered
Table 131. Karus Therapeutics Limited Main Business
Table 132. Karus Therapeutics Limited Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 133. Karus Therapeutics Limited Latest Developments
Table 134. Laboratory Corp. Of America Holdings Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 135. Laboratory Corp. Of America Holdings Personalized Medicine and Epigenomics Product Offered
Table 136. Laboratory Corp. Of America Holdings Main Business
Table 137. Laboratory Corp. Of America Holdings Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 138. Laboratory Corp. Of America Holdings Latest Developments
Table 139. LES Laboratoires Servier Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 140. LES Laboratoires Servier Personalized Medicine and Epigenomics Product Offered
Table 141. LES Laboratoires Servier Main Business
Table 142. LES Laboratoires Servier Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 143. LES Laboratoires Servier Latest Developments
Table 144. Merck Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 145. Merck Personalized Medicine and Epigenomics Product Offered
Table 146. Merck Main Business
Table 147. Merck Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 148. Merck Latest Developments
Table 149. Naturewise Biotech & Medicals Corp. Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 150. Naturewise Biotech & Medicals Corp. Personalized Medicine and Epigenomics Product Offered
Table 151. Naturewise Biotech & Medicals Corp. Main Business
Table 152. Naturewise Biotech & Medicals Corp. Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 153. Naturewise Biotech & Medicals Corp. Latest Developments
Table 154. Novartis Pharma AG Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 155. Novartis Pharma AG Personalized Medicine and Epigenomics Product Offered
Table 156. Novartis Pharma AG Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 157. Novartis Pharma AG Main Business
Table 158. Novartis Pharma AG Latest Developments
Table 159. Oncolys Biopharma Inc. Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 160. Oncolys Biopharma Inc. Personalized Medicine and Epigenomics Product Offered
Table 161. Oncolys Biopharma Inc. Main Business
Table 162. Oncolys Biopharma Inc. Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 163. Oncolys Biopharma Inc. Latest Developments
Table 164. Orchid Chemicals & Pharmaceuticals Limited Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 165. Orchid Chemicals & Pharmaceuticals Limited Personalized Medicine and Epigenomics Product Offered
Table 166. Orchid Chemicals & Pharmaceuticals Limited Main Business
Table 167. Orchid Chemicals & Pharmaceuticals Limited Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 168. Orchid Chemicals & Pharmaceuticals Limited Latest Developments
Table 169. Progen Pharmaceuticals Limited Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 170. Progen Pharmaceuticals Limited Personalized Medicine and Epigenomics Product Offered
Table 171. Progen Pharmaceuticals Limited Main Business
Table 172. Progen Pharmaceuticals Limited Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 173. Progen Pharmaceuticals Limited Latest Developments
Table 174. Quest Diagnostics Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 175. Quest Diagnostics Personalized Medicine and Epigenomics Product Offered
Table 176. Quest Diagnostics Main Business
Table 177. Quest Diagnostics Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 178. Quest Diagnostics Latest Developments
Table 179. Roche Holding AG Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 180. Roche Holding AG Personalized Medicine and Epigenomics Product Offered
Table 181. Roche Holding AG Main Business
Table 182. Roche Holding AG Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 183. Roche Holding AG Latest Developments
Table 184. Rubicon Genomics Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 185. Rubicon Genomics Personalized Medicine and Epigenomics Product Offered
Table 186. Rubicon Genomics Main Business
Table 187. Rubicon Genomics Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 188. Rubicon Genomics Latest Developments
Table 189. Takeda Pharmaceutical Company Limited Details, Company Type, Personalized Medicine and Epigenomics Area Served and Its Competitors
Table 190. Takeda Pharmaceutical Company Limited Personalized Medicine and Epigenomics Product Offered
Table 191. Takeda Pharmaceutical Company Limited Main Business
Table 192. Takeda Pharmaceutical Company Limited Personalized Medicine and Epigenomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 193. Takeda Pharmaceutical Company Limited Latest Developments
LIST OF FIGURES
Figure 1. Personalized Medicine and Epigenomics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Personalized Medicine and Epigenomics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Personalized Medicine and Epigenomics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Personalized Medicine and Epigenomics Sales Market Share by Country/Region (2023)
Figure 8. Personalized Medicine and Epigenomics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Personalized Medicine and Epigenomics Market Size Market Share by Type in 2023
Figure 10. Personalized Medicine and Epigenomics in Oncology
Figure 11. Global Personalized Medicine and Epigenomics Market: Oncology (2019-2024) & ($ Millions)
Figure 12. Personalized Medicine and Epigenomics in Non-Oncology
Figure 13. Global Personalized Medicine and Epigenomics Market: Non-Oncology (2019-2024) & ($ Millions)
Figure 14. Personalized Medicine and Epigenomics in Cancer Drug Technology
Figure 15. Global Personalized Medicine and Epigenomics Market: Cancer Drug Technology (2019-2024) & ($ Millions)
Figure 16. Global Personalized Medicine and Epigenomics Market Size Market Share by Application in 2023
Figure 17. Global Personalized Medicine and Epigenomics Revenue Market Share by Player in 2023
Figure 18. Global Personalized Medicine and Epigenomics Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Personalized Medicine and Epigenomics Market Size 2019-2024 ($ Millions)
Figure 20. APAC Personalized Medicine and Epigenomics Market Size 2019-2024 ($ Millions)
Figure 21. Europe Personalized Medicine and Epigenomics Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Personalized Medicine and Epigenomics Market Size 2019-2024 ($ Millions)
Figure 23. Americas Personalized Medicine and Epigenomics Value Market Share by Country in 2023
Figure 24. United States Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Personalized Medicine and Epigenomics Market Size Market Share by Region in 2023
Figure 29. APAC Personalized Medicine and Epigenomics Market Size Market Share by Type in 2023
Figure 30. APAC Personalized Medicine and Epigenomics Market Size Market Share by Application in 2023
Figure 31. China Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Personalized Medicine and Epigenomics Market Size Market Share by Country in 2023
Figure 38. Europe Personalized Medicine and Epigenomics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Personalized Medicine and Epigenomics Market Size Market Share by Application (2019-2024)
Figure 40. Germany Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Personalized Medicine and Epigenomics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Personalized Medicine and Epigenomics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Personalized Medicine and Epigenomics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 54. APAC Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 55. Europe Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 57. United States Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 58. Canada Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 61. China Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 62. Japan Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 63. Korea Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 65. India Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 66. Australia Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 67. Germany Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 68. France Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 69. UK Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 70. Italy Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 71. Russia Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 72. Spain Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 75. Israel Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 78. Global Personalized Medicine and Epigenomics Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Personalized Medicine and Epigenomics Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Personalized Medicine and Epigenomics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Personalized Medicine and Epigenomics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Personalized Medicine and Epigenomics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Personalized Medicine and Epigenomics Sales Market Share by Country/Region (2023)
Figure 8. Personalized Medicine and Epigenomics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Personalized Medicine and Epigenomics Market Size Market Share by Type in 2023
Figure 10. Personalized Medicine and Epigenomics in Oncology
Figure 11. Global Personalized Medicine and Epigenomics Market: Oncology (2019-2024) & ($ Millions)
Figure 12. Personalized Medicine and Epigenomics in Non-Oncology
Figure 13. Global Personalized Medicine and Epigenomics Market: Non-Oncology (2019-2024) & ($ Millions)
Figure 14. Personalized Medicine and Epigenomics in Cancer Drug Technology
Figure 15. Global Personalized Medicine and Epigenomics Market: Cancer Drug Technology (2019-2024) & ($ Millions)
Figure 16. Global Personalized Medicine and Epigenomics Market Size Market Share by Application in 2023
Figure 17. Global Personalized Medicine and Epigenomics Revenue Market Share by Player in 2023
Figure 18. Global Personalized Medicine and Epigenomics Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Personalized Medicine and Epigenomics Market Size 2019-2024 ($ Millions)
Figure 20. APAC Personalized Medicine and Epigenomics Market Size 2019-2024 ($ Millions)
Figure 21. Europe Personalized Medicine and Epigenomics Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Personalized Medicine and Epigenomics Market Size 2019-2024 ($ Millions)
Figure 23. Americas Personalized Medicine and Epigenomics Value Market Share by Country in 2023
Figure 24. United States Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Personalized Medicine and Epigenomics Market Size Market Share by Region in 2023
Figure 29. APAC Personalized Medicine and Epigenomics Market Size Market Share by Type in 2023
Figure 30. APAC Personalized Medicine and Epigenomics Market Size Market Share by Application in 2023
Figure 31. China Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Personalized Medicine and Epigenomics Market Size Market Share by Country in 2023
Figure 38. Europe Personalized Medicine and Epigenomics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Personalized Medicine and Epigenomics Market Size Market Share by Application (2019-2024)
Figure 40. Germany Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Personalized Medicine and Epigenomics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Personalized Medicine and Epigenomics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Personalized Medicine and Epigenomics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Personalized Medicine and Epigenomics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 54. APAC Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 55. Europe Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 57. United States Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 58. Canada Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 61. China Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 62. Japan Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 63. Korea Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 65. India Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 66. Australia Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 67. Germany Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 68. France Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 69. UK Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 70. Italy Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 71. Russia Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 72. Spain Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 75. Israel Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Personalized Medicine and Epigenomics Market Size 2025-2030 ($ Millions)
Figure 78. Global Personalized Medicine and Epigenomics Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Personalized Medicine and Epigenomics Market Size Market Share Forecast by Application (2025-2030)
